目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Therapy
5.1 Market segments
Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
5.2 Comparison by Therapy
Exhibit 26: Chart on Comparison by Therapy
Exhibit 27: Data Table on Comparison by Therapy
5.3 First line treatment - Market size and forecast 2021-2026
Exhibit 28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
5.4 Second line treatment - Market size and forecast 2021-2026
Exhibit 32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Therapy
Exhibit 36: Market opportunity by Therapy ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 UK - Market size and forecast 2021-2026
Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.11 France - Market size and forecast 2021-2026
Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Amgen Inc.
Exhibit 85: Amgen Inc. - Overview
Exhibit 86: Amgen Inc. - Product / Service
Exhibit 87: Amgen Inc. - Key offerings
10.4 AMYRA Biotech AG
Exhibit 88: AMYRA Biotech AG - Overview
Exhibit 89: AMYRA Biotech AG - Product / Service
Exhibit 90: AMYRA Biotech AG - Key offerings
10.5 BioLineRx Ltd.
Exhibit 91: BioLineRx Ltd. - Overview
Exhibit 92: BioLineRx Ltd. - Product / Service
Exhibit 93: BioLineRx Ltd. - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 94: Bristol Myers Squibb Co. - Overview
Exhibit 95: Bristol Myers Squibb Co. - Product / Service
Exhibit 96: Bristol Myers Squibb Co. - Key offerings
10.7 Calypso Biotech
Exhibit 97: Calypso Biotech - Overview
Exhibit 98: Calypso Biotech - Product / Service
Exhibit 99: Calypso Biotech - Key offerings
10.8 GlaxoSmithKline Plc
Exhibit 100: GlaxoSmithKline Plc - Overview
Exhibit 101: GlaxoSmithKline Plc - Business segments
Exhibit 102: GlaxoSmithKline Plc - Key news
Exhibit 103: GlaxoSmithKline Plc - Key offerings
Exhibit 104: GlaxoSmithKline Plc - Segment focus
10.9 Immunogenics LLC
Exhibit 105: Immunogenics LLC - Overview
Exhibit 106: Immunogenics LLC - Product / Service
Exhibit 107: Immunogenics LLC - Key offerings
10.10 Johnson and Johnson
Exhibit 108: Johnson and Johnson - Overview
Exhibit 109: Johnson and Johnson - Business segments
Exhibit 110: Johnson and Johnson - Key news
Exhibit 111: Johnson and Johnson - Key offerings
Exhibit 112: Johnson and Johnson - Segment focus
10.11 Sanofi
Exhibit 113: Sanofi - Overview
Exhibit 114: Sanofi - Business segments
Exhibit 115: Sanofi - Key news
Exhibit 116: Sanofi - Key offerings
Exhibit 117: Sanofi - Segment focus
10.12 Takeda Pharmaceutical Co. Ltd.
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 122: Inclusions checklist
Exhibit 123: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 124: Currency conversion rates for US$
11.4 Research methodology
Exhibit 125: Research methodology
Exhibit 126: Validation techniques employed for market sizing
Exhibit 127: Information sources
11.5 List of abbreviations
Exhibit 128: List of abbreviations
health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on First line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on First line treatment - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Second line treatment - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Second line treatment - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Therapy ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Amgen Inc. - Overview
Exhibits86: Amgen Inc. - Product / Service
Exhibits87: Amgen Inc. - Key offerings
Exhibits88: AMYRA Biotech AG - Overview
Exhibits89: AMYRA Biotech AG - Product / Service
Exhibits90: AMYRA Biotech AG - Key offerings
Exhibits91: BioLineRx Ltd. - Overview
Exhibits92: BioLineRx Ltd. - Product / Service
Exhibits93: BioLineRx Ltd. - Key offerings
Exhibits94: Bristol Myers Squibb Co. - Overview
Exhibits95: Bristol Myers Squibb Co. - Product / Service
Exhibits96: Bristol Myers Squibb Co. - Key offerings
Exhibits97: Calypso Biotech - Overview
Exhibits98: Calypso Biotech - Product / Service
Exhibits99: Calypso Biotech - Key offerings
Exhibits100: GlaxoSmithKline Plc - Overview
Exhibits101: GlaxoSmithKline Plc - Business segments
Exhibits102: GlaxoSmithKline Plc - Key news
Exhibits103: GlaxoSmithKline Plc - Key offerings
Exhibits104: GlaxoSmithKline Plc - Segment focus
Exhibits105: Immunogenics LLC - Overview
Exhibits106: Immunogenics LLC - Product / Service
Exhibits107: Immunogenics LLC - Key offerings
Exhibits108: Johnson and Johnson - Overview
Exhibits109: Johnson and Johnson - Business segments
Exhibits110: Johnson and Johnson - Key news
Exhibits111: Johnson and Johnson - Key offerings
Exhibits112: Johnson and Johnson - Segment focus
Exhibits113: Sanofi - Overview
Exhibits114: Sanofi - Business segments
Exhibits115: Sanofi - Key news
Exhibits116: Sanofi - Key offerings
Exhibits117: Sanofi - Segment focus
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits121: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations